NEW YORK MORTGAGE TRUST, INC. 2,750,000 Shares of Common Stock* UNDERWRITING AGREEMENTUnderwriting Agreement • May 31st, 2012 • New York Mortgage Trust Inc • Real estate investment trusts • New York
Contract Type FiledMay 31st, 2012 Company Industry JurisdictionNew York Mortgage Trust, Inc., a Maryland corporation (the “Company”), proposes to issue and sell, subject to the conditions hereinafter stated, to the several Underwriters named in Schedule I attached hereto (the “Underwriters”) an aggregate of 2,750,000 shares (the “Firm Securities”) of its common stock, $0.01 par value per share (“Common Stock”), pursuant to and in accordance with the terms and conditions of this underwriting agreement (this “Agreement”) in connection with the public offering (the “Offering”) and sale of such Firm Securities.
NEW YORK MORTGAGE TRUST, INC. 1,500,000 Shares of Common Stock* UNDERWRITING AGREEMENTUnderwriting Agreement • June 30th, 2011 • New York Mortgage Trust Inc • Real estate investment trusts • New York
Contract Type FiledJune 30th, 2011 Company Industry JurisdictionNew York Mortgage Trust, Inc., a Maryland corporation (the “Company”), proposes to issue and sell, subject to the conditions hereinafter stated, to the several Underwriters named in Schedule I attached hereto (the “Underwriters”) an aggregate of 1,500,000 shares (the “Firm Securities”) of its common stock, $0.01 par value per share (“Common Stock”), pursuant to and in accordance with the terms and conditions of this underwriting agreement (this “Agreement”) in connection with the public offering (the “Offering”) and sale of such Firm Securities.
690,000 Units REPROS THERAPEUTICS INC. Each Unit consisting of 4 Shares of Common Stock and 3 Series A Warrants and 2.45 Series B Warrants UNDERWRITING AGREEMENTUnderwriting Agreement • February 9th, 2011 • Repros Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 9th, 2011 Company Industry JurisdictionBased on the foregoing, and subject to the assumptions, qualifications and limitations set forth herein, as of the date hereof we are of the opinion that:
] Units REPROS THERAPEUTICS INC. Each Unit consisting of [ ] Shares of Common Stock and [ ] Series A Warrants and [ ] Series B Warrants UNDERWRITING AGREEMENTUnderwriting Agreement • February 2nd, 2011 • Repros Therapeutics Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledFebruary 2nd, 2011 Company Industry JurisdictionBased on the foregoing, and subject to the assumptions, qualifications and limitations set forth herein, as of the date hereof we are of the opinion that:
900,000 Units CELSIUS HOLDINGS, INC. Each Unit consisting of Four Shares of Common Stock and One Warrant, each to Purchase One Share of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 8th, 2010 • Celsius Holdings, Inc. • Bottled & canned soft drinks & carbonated waters • New York
Contract Type FiledFebruary 8th, 2010 Company Industry JurisdictionCELSIUS HOLDINGS, INC, a Nevada corporation (the “Company”), proposes to issue and sell to the several Underwriters (as defined below) an aggregate of (i) 3,600,000 shares (the “Shares”) of its common stock, $0.001 par value per share (the “Common Stock”) and (ii) warrants (the “Warrants”) to purchase up to an aggregate of 900,000 shares of Common Stock (the “Warrant Shares”) pursuant to and in accordance with the terms and conditions of this underwriting agreement (the “Agreement”). The Shares and Warrants shall be sold in units (each a “Unit”), each Unit consisting of four (4) Shares and one (1) Warrant, each to purchase one (1) Warrant Share at the exercise price per share specified in the Prospectus (as defined below). The Shares and the Warrants shall be issued separately and shall be transferable separately immediately upon issuance. The Warrants will be issued pursuant to the terms of a Warrant Agreement (the “Warrant Agreement”) to be entered into by and between the Company and
900,000 Units CELSIUS HOLDINGS, INC. Each Unit consisting of Four Shares of Common Stock and One Warrant, each to Purchase One Share of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • January 22nd, 2010 • Celsius Holdings, Inc. • Bottled & canned soft drinks & carbonated waters • New York
Contract Type FiledJanuary 22nd, 2010 Company Industry JurisdictionCELSIUS HOLDINGS, INC, a Nevada corporation (the “Company”), proposes to issue and sell to the several Underwriters (as defined below) an aggregate of (i) 3,600,000 shares (the “Shares”) of its common stock, $0.001 par value per share (the “Common Stock”) and (ii) warrants (the “Warrants”) to purchase up to an aggregate of 900,000 shares of Common Stock (the “Warrant Shares”) pursuant to and in accordance with the terms and conditions of this underwriting agreement (the “Agreement”). The Shares and Warrants shall be sold in units (each a “Unit”), each Unit consisting of four (4) Shares and one (1) Warrant, each to purchase one (1) Warrant Share at the exercise price per share specified in the Prospectus (as defined below). The Shares and the Warrants shall be issued separately and shall be transferable separately immediately upon issuance. The Warrants will be issued pursuant to the terms of a Warrant Agreement (the “Warrant Agreement”) to be entered into by and between the Company and
3,500,000 Shares and 3,500,000 Warrants OPEXA THERAPEUTICS, INC. Common Stock and Common Stock Purchase Warrants UNDERWRITING AGREEMENT February 13, 2008Underwriting Agreement • February 14th, 2008 • Opexa Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledFebruary 14th, 2008 Company Industry Jurisdiction
4,500,000 Shares and 4,500,000 Warrants OPEXA THERAPEUTICS, Inc. Common Stock and Common Stock Purchase Warrants UNDERWRITING AGREEMENTUnderwriting Agreement • December 20th, 2007 • Opexa Therapeutics, Inc. • Pharmaceutical preparations • California
Contract Type FiledDecember 20th, 2007 Company Industry JurisdictionOpexa Therapeutics, Inc., a Texas corporation (“Company”), proposes to issue and sell to the several Underwriters (as defined below) an aggregate of 4,500,000 shares of its common stock, $0.50 par value per share (the “Common Stock”) and an aggregate of 4,500,000 common stock purchase warrants, each warrant to purchase one share of common stock for an exercise period of five years commencing the date of issuance (the “Public Series E Warrants”).
4,500,000 Shares HQ SUSTAINABLE MARITIME INDUSTRIES, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • November 8th, 2007 • Hq Sustainable Maritime Industries, Inc. • Fishing, hunting and trapping • New York
Contract Type FiledNovember 8th, 2007 Company Industry Jurisdiction
4,200,000 Shares HQ SUSTAINABLE MARITIME INDUSTRIES, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • May 24th, 2007 • Hq Sustainable Maritime Industries, Inc. • Fishing, hunting and trapping • New York
Contract Type FiledMay 24th, 2007 Company Industry Jurisdiction
4,025,000 Shares OCULUS INNOVATIVE SCIENCES, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • January 3rd, 2007 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • California
Contract Type FiledJanuary 3rd, 2007 Company Industry JurisdictionRoth Capital Partners, LLC As Representative of the Several Underwriters named in Schedule I hereto 24 Corporate Plaza Newport Beach, CA 92660
3,538,461 Shares OCULUS INNOVATIVE SCIENCES, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • December 20th, 2006 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • California
Contract Type FiledDecember 20th, 2006 Company Industry JurisdictionRoth Capital Partners, LLC As Representative of the Several Underwriters named in Schedule I hereto 24 Corporate Plaza Newport Beach, CA 92660
3,538,461 Shares OCULUS INNOVATIVE SCIENCES, INC. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • December 18th, 2006 • Oculus Innovative Sciences, Inc. • Surgical & medical instruments & apparatus • California
Contract Type FiledDecember 18th, 2006 Company Industry JurisdictionRoth Capital Partners, LLC As Representative of the Several Underwriters named in Schedule I hereto 24 Corporate Plaza Newport Beach, CA 92660